AzTrials
AzTrials

Iodine DisordersNCT02915536

Exploration of Effects of Excessive Iodine on Children and Tolerable Upper Intake Level of Iodine for Children

An observational study of Iodine Disorders, run by Wanqi Zhang.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

With the implementation of Universal Salt Iodization (USI) in 1995, China has successfully combated Iodine Deficiency Diseases (IDD). However, China is a country with a complicated iodine geographical environment with wide natural variation in the iodine content of drinking water. Read more about this study

Who is it for?
Ages 7 to 14 years
Conditions the study is for
Iodine Disorders
What is being tested?
Natural exposure of high iodine
How many people
2,229 participants
Where
No sites listed yet
Study dates
Jan 2013to Mar 2016
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: High water iodine areas in Shandong are far-ranging. An investigation in 2005 showed that water iodine content exceeded 150μg/L in 17 of the 20 counties, while water iodine in the other 3 exceeded 300μg/L. Regions with water iodine content in the range of 150-800µg/L were chosen as, with a corresponding UIE range of 300-800µg/L, were selected as high iodine intake (HI) areas for the study. Regions with water iodine content in the range of 10-100µg/L with a corresponding UIE range of 100-299µg/L were selected as adequate iodine intake (AI) study areas. Areas with high fluorine will be excluded. One to six primary schools were selected from each city by randomly sampling. Children were selected from these schools.

Who may be able to join

  • Healthy
  • Native born or residents of Shandong province for at least 5 years.

Who cannot join

  • Previous history of thyroid diseases or medication intake (including iodine supplements)
  • protein-energy malnutrition in the long term

About this study

With the implementation of Universal Salt Iodization (USI) in 1995, China has successfully combated Iodine Deficiency Diseases (IDD). However, China is a country with a complicated iodine geographical environment with wide natural variation in the iodine content of drinking water. It has been reported that the water iodine of at least 11 provinces and cities in China is high, with nearly 31 million people exposed to the risks of excessive iodine intake. This has raised a new public health concern that a safe upper level of iodine intake should be established to ensure that people avoid ingesting excessive iodine intake while continuing to implement USI to control IDD. The investigators have successfully explored the tolerable upper intake level (UL) of iodine for Chinese adults by conducting a randomized double-blinded trial in 256 euthyroid volunteers. However, due to limited data on the safe upper intake level of iodine for children worldwide, current ULs of iodine for children are extrapolated from those for adults based on body weight or body surface area. As it is impossible to ethically conduct a randomized clinical trial regarding excessive iodine intake in children, the investigators plan an observational study to investigate children who have been living with different drinking water iodine levels for over 5 years, observing the changes of thyroid function in response to each iodine exposure level. Subtle changes in thyroid function and thyroid volume of children corresponding to different iodine intake levels will be determined, which will contribute to the establishment of UL of iodine for children.

The aim was:

  1. To establish the tolerable upper intake level (UL) of iodine for children of China.
  2. To define the adverse effects of excess iodine on children.
  3. To monitor the iodine status of children living in high water iodine areas in China.
Read the detailed description

The project is designed as a cross-sectional comparative epidemiological study, to be conducted in areas with high water iodine and adequate iodine intake, respectively. The research will include the following three stages.

First stage: In an initial contact phase of the study, workshops on the subject matter will be held in Shandong province. Regions will be sampled according to the monitoring data on water iodine collected by the Shandong Institute for Endemic Disease Control and Research, which will be a collaborative department for this study, as well as the pre-investigation. Areas in Shandong with water iodine ranging from 150μg/L to 800μg/L iodine, corresponding to urinary iodine excretion (UIE) of 300-800μg/L, will be investigated as high iodine intake areas (HI); regions with varying water iodine levels within this range will be included. Matching areas in Shandong with 10-100μg/L iodine in water, corresponding to UIE of 100-299μg/L, will be selected as the comparison areas of adequate iodine intake (AI). Refresher courses will be given to investigators and the capacity of laboratory staff will be updated. All relevant local authorities will be properly contacted. Pre-investigations will be conducted to determine the water iodine level and the former iodine status of residents, which will help the investigators to select suitable study areas. A pilot study will be conducted in a small number of subjects, including 24h urine collection and 3d dietary record to ensure that these methods are appropriate and feasible.

Second stage: A cross-sectional study of iodine intake and thyroid function in 7-14-yr-old children will be carried out. This stage mainly includes two parts.

In Part 1, 24-h and spot urinary samples (2 times) from all children will be collected to precisely evaluate the daily iodine intake of subjects. Spot urinary samples will be taken before collection of the 24-h urine samples. Teachers and parents will be trained to help children in performing the collection. 3d dietary records will be used to collect information on food and nutrient intake of participants. The parents (or guardian) and children will be trained on how to record food intake. The dietary record may be started any day of a week and correspond to the day of urine collection. The record will comprise all home food and water intake as well as out-of-home food consumption. Food frequency questionnaires (FFQ) will be used in combination with the dietary records to evaluate long-term habitual iodine intake. Simultaneously, food samples, including locally-consumed foods with relatively high iodine content and those which local residents generally consume frequently, will be sampled to determine iodine content, as will salt and water.

In Part 2, Blood samples will be collected to evaluate thyroid function and thyroid auto-antibodies, and thyroid volume of children will be detected by ultrasonography which will be conducted by professional technicians

Third stage: Iodine intake of all children will be calculated precisely and comprehensively through both 24-h UIE and dietary iodine intake (as described in Part 1). Adverse effects will be defined by parameters detected in Part 2.

Being tested
Natural exposure of high iodine
Keywords
iodine excess, thyroid disease, children, tolerable upper intake level
Medical subject headings
Thyroid Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Natural exposure of high iodineOther

    Natural exposure of high iodine intake from drinking water

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. thyroid goiter confirmed by ultrasonographic thyroid volume

    Measured: 1 year

Secondary outcomes (1)
  1. thyroid dysfunction confirmed by serum concentrations of FT4, FT3, and TSH with an automated chemiluminescent immunoassay by using diagnostic kits from Bayer Health Care, Siemens

    Measured: 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Sep 2016 (estimated)
  2. Study startJan 2013
  3. Primary completionSep 2015
  4. Study completionMar 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Time perspective
Cross-sectional
Enrolment
2,229 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02915536
Sponsor's protocol ID
NSFC-81273057
Other IDs
Nestlé Foundation, NSFC
Status last verified
Sep 2016
First submitted
20 Sep 2016
Last updated
29 Sep 2016
Results posted
No
Data monitoring committee
No
Individual data sharing
Undecided

Publications

  • Teng W, Shan Z, Teng X, Guan H, Li Y, Teng D, Jin Y, Yu X, Fan C, Chong W, Yang F, Dai H, Yu Y, Li J, Chen Y, Zhao D, Shi X, Hu F, Mao J, Gu X, Yang R, Tong Y, Wang W, Gao T, Li C. Effect of iodine intake on thyroid diseases in China. N Engl J Med. 2006 Jun 29;354(26):2783-93. doi: 10.1056/NEJMoa054022.

    PubMed 16807415
  • Laurberg P, Bulow Pedersen I, Knudsen N, Ovesen L, Andersen S. Environmental iodine intake affects the type of nonmalignant thyroid disease. Thyroid. 2001 May;11(5):457-69. doi: 10.1089/105072501300176417.

    PubMed 11396704
  • Izzeldin HS, Crawford MA, Jooste PL. Population living in the Red Sea State of Sudan may need urgent intervention to correct the excess dietary iodine intake. Nutr Health. 2007;18(4):333-41. doi: 10.1177/026010600701800403.

    PubMed 18087865
  • Sang Z, Wang PP, Yao Z, Shen J, Halfyard B, Tan L, Zhao N, Wu Y, Gao S, Tan J, Liu J, Chen Z, Zhang W. Exploration of the safe upper level of iodine intake in euthyroid Chinese adults: a randomized double-blind trial. Am J Clin Nutr. 2012 Feb;95(2):367-73. doi: 10.3945/ajcn.111.028001. Epub 2011 Dec 28.

    PubMed 22205314
  • Laurberg P, Pedersen KM, Hreidarsson A, Sigfusson N, Iversen E, Knudsen PR. Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. J Clin Endocrinol Metab. 1998 Mar;83(3):765-9. doi: 10.1210/jcem.83.3.4624.

    PubMed 9506723
  • Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, Pedersen IB, Carle A. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab. 2010 Feb;24(1):13-27. doi: 10.1016/j.beem.2009.08.013.

    PubMed 20172467
  • Su X., Liu S., Shen H., Zhang S., Wei H., Yu J., Ye Y., Li Y., Liu Y., Zhang Z., Sun D. National iodine deficiency disorder surveillance: a sum up of data in 2005 and an analysis. Chinese Journal of Endemiology. 2007, 26(1): 67-69.

  • Zimmermann MB, Andersson M. Assessment of iodine nutrition in populations: past, present, and future. Nutr Rev. 2012 Oct;70(10):553-70. doi: 10.1111/j.1753-4887.2012.00528.x.

    PubMed 23035804
  • Pearce EN, Gerber AR, Gootnick DB, Khan LK, Li R, Pino S, Braverman LE. Effects of chronic iodine excess in a cohort of long-term American workers in West Africa. J Clin Endocrinol Metab. 2002 Dec;87(12):5499-502. doi: 10.1210/jc.2002-020692.

    PubMed 12466344
  • Burgi H. Iodine excess. Best Pract Res Clin Endocrinol Metab. 2010 Feb;24(1):107-15. doi: 10.1016/j.beem.2009.08.010.

    PubMed 20172475
  • Zimmermann MB, Ito Y, Hess SY, Fujieda K, Molinari L. High thyroid volume in children with excess dietary iodine intakes. Am J Clin Nutr. 2005 Apr;81(4):840-4. doi: 10.1093/ajcn/81.4.840.

    PubMed 15817861
  • Ergur AT, Evliyaoglu O, Siklar Z, Bilir P, Ocal G, Berberoglu M. Evaluation of thyroid functions with respect to iodine status and TRH test in chronic autoimmune thyroiditis. J Clin Res Pediatr Endocrinol. 2011;3(1):18-21. doi: 10.4274/jcrpe.v3i1.04. Epub 2011 Feb 23.

    PubMed 21448329
  • Shen H., Zhang S., Liu S., Su X., Shen Y., Han H. Study on the geographic distribution of national high water iodine areas and the contours of water iodine in high iodine areas. Chinese Journal of Endemiology. 2007, 26(6): 658-661.

  • Guo X., Wang X., Liu Y., Huang J., Zhai L., Chen Z. Investigation of distribution of high water iodine areas of northwestern Shandong and the current status of inhabitant edible salt. Chinese Journal of Preventive Medicine. 2005, 39(2): 77-78.

  • WHO/UNICEF/ICCIDD. Assessment of iodine deficiency disorders and monitoring their elimination. 3rd ed. Geneva, 2007.

Questions about this trial

What is this clinical trial studying?

An observational study of Iodine Disorders, run by Wanqi Zhang.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 29 Sep 2016. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

thyroid goiter confirmed by ultrasonographic thyroid volume (time frame: 1 year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02915536, which also lists 24 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Sep 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in